Table 3.
PT at different concentrations |
APTT at different concentrations |
||||||
---|---|---|---|---|---|---|---|
Crude extract of F. carica proteases |
FPIII |
Crude extract of F. carica proteases |
FPIII |
||||
μg proteins | PT Sec. | μg proteins (0.4 μM) | PT Sec. | μg proteins | APTT Sec. | μg proteins (0.4 μM) | APTT Sec. |
13 | 15 ± 0.6 | 5.6 | >300 | 13 | 14 ± 0.5 | 5.6 | >300 |
26 | 18 ± 0.6 | 26 | 26 ± 1.0 | ||||
39 | 25 ± 1.0 | 39 | 38 ± 1.5 | ||||
52 | 35 ± 2.1 | 52 | 49 ± 2.0 | ||||
65 | 59 ± 1.5 | 65 | 63 ± 2.0 | ||||
78 | 82 ± 2.5 | 78 | 97 ± 3.0 | ||||
91 | 128 ± 3.0 | 91 | 175 ± 1.5 | ||||
104 | 200 ± 4.0 | 104 | 219 ± 3.0 | ||||
117 | 263 ± 3.2 | 117 | 270 ± 2.0 | ||||
control | 30 | control | 47 |
The different concentrations of crude extract of F. carica proteases and FPIII were pre-incubated with 10 mM BaCl2. The control is the clotting time of the human plasma contained 10 mM BaCl2 in absence of anticoagulant. n = 3. The results are presented as the mean ± SD.